(Q43236130)

16 November 2017

title

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma (English)

1 reference

16 November 2017

Peng Xie

1

1 reference

16 November 2017

Jin-Bo Yue

2

1 reference

16 November 2017

Han-Xi Zhao

3

1 reference

16 November 2017

Xin-Dong Sun

4

1 reference

16 November 2017

Li Kong

5

1 reference

16 November 2017

Zheng Fu

6

1 reference

16 November 2017

Jin-Ming Yu

7

1 reference

16 November 2017

publication date

20 November 2009

1 reference

Journal of Cancer Research and Clinical Oncology

16 November 2017

published in

1 reference

16 November 2017

volume

136

1 reference

16 November 2017

issue

6

1 reference

16 November 2017

page(s)

883-889

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0729-7

16 November 2017

exact match

0 references

cites work

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Metabolic tumor burden predicts for disease progression and death in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-009-0729-7

Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA

21 January 2018

1 reference

12 December 2020

Ensuring the right PET scan for the right patient.

1 reference

12 December 2020

Revised response criteria for malignant lymphoma

1 reference

12 December 2020

Anatomy of SUV. Standardized uptake value

1 reference

12 December 2020

Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.

1 reference

12 December 2020

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

1 reference

12 December 2020

Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value

1 reference

12 December 2020

Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.

1 reference

12 December 2020

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

1 reference

12 December 2020

Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

1 reference

12 December 2020

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

12 December 2020

Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1.

1 reference

12 December 2020

Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emi

1 reference

12 December 2020

Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status.

1 reference

12 December 2020

Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus

1 reference

12 December 2020

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

1 reference

12 December 2020

The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer

1 reference

12 December 2020

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

12 December 2020

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

1 reference

12 December 2020

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

1 reference

12 December 2020

Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy

1 reference

12 December 2020

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

1 reference

12 December 2020

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

12 December 2020

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

12 December 2020

10.1007/S00432-009-0729-7

Identifiers

DOI

1 reference

16 November 2017

1 reference